Healthcare -
Biotechnology - NASDAQ - US
$ 5.01
5.92 %
$ 322 M
Market Cap
-5.06
P/E
CRVS - INTEREST INCOME & EXPENSE
Interest Income & Expense CRVS - Corvus Pharmaceuticals, Inc.
1.58 M
LAST VALUE
927.62%
2 YEAR CAGR
-7.05%
5 YEAR CAGR
0.00%
10 YEAR CAGR